|
|
Volumn 83, Issue 5, 1998, Pages 830-834
|
|
Prevention of osteoporosis in women treated for hereditary breast and ovarian carcinoma: A need that is overlooked
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ANTIESTROGEN;
BISPHOSPHONIC ACID DERIVATIVE;
CAFFEINE;
CALCITONIN;
CALCIUM;
CALCIUM CARBONATE;
CITRATE CALCIUM;
ETIDRONIC ACID;
FLUORIDE;
RALOXIFENE;
SODIUM;
TAMOXIFEN;
TUMS;
UNCLASSIFIED DRUG;
VITAMIN D;
ALCOHOL CONSUMPTION;
BREAST CARCINOMA;
CALCIUM INTAKE;
CLINICAL TRIAL;
DIET SUPPLEMENTATION;
DRUG ABSORPTION;
DRUG EFFECT;
DRUG MECHANISM;
ENDOMETRIUM HYPERPLASIA;
EXERCISE;
FAMILIAL CANCER;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRANASAL DRUG ADMINISTRATION;
LIFESTYLE;
OSTEOPOROSIS;
OVARY CARCINOMA;
PRIORITY JOURNAL;
REVIEW;
SMOKING;
SODIUM INTAKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
ALENDRONATE;
BREAST NEOPLASMS;
CALCITONIN;
DIET;
DIPHOSPHONATES;
EXERCISE THERAPY;
FEMALE;
HUMANS;
LIFE STYLE;
NEOPLASTIC SYNDROMES, HEREDITARY;
OSTEOPOROSIS;
OVARIAN NEOPLASMS;
|
|
EID: 0032169057
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(19980901)83:5<830::AID-CNCR2>3.0.CO;2-M Document Type: Review |
|
Times cited : (10)
|
|
References (41)
|
